Tryptophan metabolism in health and disease- implications for non-communicable diseases
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IDO1 induction diverts tryptophan flux from serotonin synthesis toward kynurenine and its downstream metabolites, resulting in central serotonin deficiency while generating neuroactive metabolites that directly affect neuronal function [50].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
Lamas, B., Richard, M. L., Leducq, V., Pham, H.-P., Michel, M.-L., Da Costa, G., Bridonneau, C., Jegou, S., Hoffmann, T. W., Natividad, J. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4102 · Cited by 1,482
A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites
Dodd, D., Spitzer, M. H., Van Treuren, W., Merrill, B. D., Hryckowian, A. J., Higginbottom, S. K., Le, A., Cowan, T. M., Nolan, G. P., Fischbach, M. A., et al. (2017) · Nature · doi:10.1038/nature24661 · Cited by 1,425
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
Reigstad, C. S., Salmonson, C. E., III, J. F. R., Szurszewski, J. H., Linden, D. R., Sonnenburg, J. L., Farrugia, G., & Kashyap, P. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-259598 · Cited by 1,335
Salt-responsive gut commensal modulates TH17 axis and disease
Wilck, N., Matus, M. G., Kearney, S. M., Olesen, S. W., Forslund, K., Bartolomaeus, H., Haase, S., Mähler, A., Balogh, A., Markó, L., et al. (2017) · Nature · doi:10.1038/nature24628 · Cited by 1,310
Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects
Badawy, A. A.-B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691938 · Cited by 1,158
Venkatesh, M., Mukherjee, S., Wang, H., Li, H., Sun, K., Benechet, A. P., Qiu, Z., Maher, L., Redinbo, M. R., Phillips, R. S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.014 · Cited by 1,066
Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain
Gao, K., Mu, C.-L., Farzi, A., & Zhu, W.-Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz127 · Cited by 1,029
Research works printed but not linked: 118
- Strasser, 2016, Mood, food, and cognition: role of tryptophan and serotonin, Curr. Opin. Clin. Nutr. Metab. Care, 19, 55
- Savitz, 2020, The kynurenine pathway: a finger in every pie, Mol. Psychiatry, 25, 131, 10.1038/s41380-019-0414-4 · DOI · Paper page
- Xue, 2023, Tryptophan metabolism in health and disease, Cell Metab., 35, 1304, 10.1016/j.cmet.2023.06.004 · DOI · Paper page
- Zou, 2015, Tryptophan-kynurenine pathway is dysregulated in inflammation and immune activation, Front. Biosci., 20, 4363, 10.2741/4363 · DOI · Paper page
- Seo, 2023, Immune regulation through tryptophan metabolism, Exp. Mol. Med., 55, 1371, 10.1038/s12276-023-01028-7 · DOI · Paper page
- O’Mahony, 2015, Serotonin, tryptophan metabolism and the brain-gut-microbiome axis, Behav. Brain Res., 277, 32, 10.1016/j.bbr.2014.07.027 · DOI · Paper page
- Park, 2021, A systems biology approach to investigating the interaction between serotonin synthesis by tryptophan hydroxylase and the metabolic homeostasis, Int. J. Mol. Sci., 22, 2452, 10.3390/ijms22052452 · DOI
- Haq, 2021, Tryptophan-derived serotonin-kynurenine balance in immune activation and intestinal inflammation, FASEB J., 35, 10.1096/fj.202100702R · DOI
- Höglund, 2019, Tryptophan metabolic pathways and brain serotonergic activity: a comparative review, Front. Endocrinol., 10, 10.3389/fendo.2019.00158 · DOI · Paper page
- Mohammad-Zadeh, 2008, Serotonin: a review, J. Vet. Pharmacol. Ther., 31, 187, 10.1111/j.1365-2885.2008.00944.x · DOI · Paper page
- Fiore, 2021, Tryptophan and indole metabolism in immune regulation, Curr. Opin. Immunol., 70, 7, 10.1016/j.coi.2020.12.001 · DOI · Paper page
- Zelante, 2013, Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22, Immunity, 39, 372, 10.1016/j.immuni.2013.08.003 · DOI · Paper page
- Lamas, 2018, Aryl hydrocarbon receptor and intestinal immunity, Mucosal. Immunol., 11, 1024, 10.1038/s41385-018-0019-2 · DOI · Paper page
- Wlodarska, 2017, Indoleacrylic acid produced by commensal peptostreptococcus species suppresses inflammation, Cell Host. Microbe, 22, 25, 10.1016/j.chom.2017.06.007 · DOI · Paper page
- Carbonnelle-Puscian, 2009, The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages, Leukemia, 23, 952, 10.1038/leu.2008.380 · DOI
- Boulland, 2007, Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation, Blood, 110, 220, 10.1182/blood-2006-07-036210 · DOI · Paper page
- Yue, 2015, IL4I1 is a novel regulator of M2 macrophage polarization that can inhibit t cell activation via l-tryptophan and arginine depletion and IL-10 production, PLoS One, 10, 10.1371/journal.pone.0142979 · DOI
- Boulland, 2007, Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation, Blood, 110, 220, 10.1182/blood-2006-07-036210 · DOI · Paper page
- Ye, 2020, Mucosal-associated invariant T cells restrict allergic airway inflammation, J. Allergy Clin. Immunol., 145, 1469, 10.1016/j.jaci.2019.12.891 · DOI
- Scarlata, 2015, Differential expression of the immunosuppressive enzyme IL4I1 in human induced Aiolos+, but not natural Helios+, FOXP3+ treg cells, Eur. J. Immunol., 45, 474, 10.1002/eji.201444897 · DOI
- Cousin, 2015, The immunosuppressive enzyme IL4I1 promotes FoxP3+ regulatory T lymphocyte differentiation, Eur. J. Immunol., 45, 1772, 10.1002/eji.201445000 · DOI
- Bod, 2018, IL-4–Induced gene 1: a negative immune checkpoint controlling B cell differentiation and activation, J. Immunol., 200, 1027, 10.4049/jimmunol.1601609 · DOI
- Puiffe, 2013, Antibacterial properties of the mammalian l-amino acid oxidase IL4I1, PLoS One, 8, 2, 10.1371/journal.pone.0054589 · DOI
- Presset, 2020, Identification of inhibitors of the immunosuppressive enzyme IL4I1, Bioorg. Chem., 94, 10.1016/j.bioorg.2019.103463 · doi:10.1016/j.bioorg.2019.103463
- Sadik, 2020, IL4I1 Is a metabolic immune checkpoint that activates the AHR and promotes tumor progression, Cell, 182, 1252, 10.1016/j.cell.2020.07.038 · DOI · Paper page
- Romagnani, 2016, IL4I1: key immunoregulator at a crossroads of divergent T-cell functions, Eur. J. Immunol., 46, 2302, 10.1002/eji.201646617 · DOI
- Zeitler, 2021, Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism, Elife, 10, 1, 10.7554/eLife.64806 · DOI
- Sadik, 2020, IL4I1 Is a metabolic immune checkpoint that activates the AHR and promotes tumor progression, Cell, 182, 1252, 10.1016/j.cell.2020.07.038 · DOI · Paper page
- Rannug, 2022, 6-Formylindolo[3,2-b]carbazole, a potent ligand for the aryl hydrocarbon receptor produced both endogenously and by microorganisms, can either promote or restrain inflammatory responses, Front. Toxicol., 4
- Zeitler, 2023, IL4i1 and IDO1: oxidases that control a tryptophan metabolic nexus in cancer, J. Biol. Chem., 299, 10.1016/j.jbc.2023.104827 · DOI
- Agus, 2018, Gut microbiota regulation of tryptophan metabolism in health and disease, Cell Host. Microbe, 23, 716, 10.1016/j.chom.2018.05.003 · DOI · Paper page
- Perdijk, 2024, Antibiotic-driven dysbiosis in early life disrupts indole-3-propionic acid production and exacerbates allergic airway inflammation in adulthood, Immunity, 10.1016/j.immuni.2024.06.010 · DOI
- Michaudel, 2020, Ozone-induced aryl hydrocarbon receptor activation controls lung inflammation via interleukin-22 modulation, Front. Immunol., 11
- D. Tang, L. Yue, R. Yao, L. Zhou, Y. Yang, L. Lu, W. Gao, P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer, 2017. www.impactjournals.com/oncotarget. · DOI
- Wang, 2024, Gut microbiota-derived tryptophan metabolites alleviate allergic asthma inflammation in ovalbumin-induced mice, Foods, 13
- Larabi, 2023, Bile acids as modulators of gut microbiota composition and function, Gut Microbes, 15, 10.1080/19490976.2023.2172671 · DOI · Paper page
- Wheeler, 2013, Novel cellular targets of AhR underlie alterations in neutrophilic inflammation and inducible nitric oxide synthase expression during Influenza Virus infection, J. Immunol., 190, 659, 10.4049/jimmunol.1201341 · DOI · Paper page
- Zhang, 2024, Metabolomics identifies phenotypic biomarkers of amino acid metabolism in milk allergy and sensitized tolerance, J. Allergy Clin. Immunol., 154, 157, 10.1016/j.jaci.2024.02.023 · DOI
- Miao, 2024, Impaired tryptophan metabolism by type 2 inflammation in epithelium worsening asthma, iScience, 27, 10.1016/j.isci.2024.109923 · DOI
- Paveglio, 2011, Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure, Am. J. Respir. Cell Mol. Biol., 44, 11, 10.1165/rcmb.2009-0167OC · DOI
- Ruan, 2025, The tryptophan metabolite 3-hydroxyanthranilic acid alleviates hyperoxia-induced bronchopulmonary dysplasia via inhibiting ferroptosis, Redox. Biol., 82, 10.1016/j.redox.2025.103579 · DOI
- Cervantes-Barragan, 2017, Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells, Science, 357, 806, 10.1126/science.aah5825 · DOI · Paper page
- Yano, 2015, Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis, Cell, 161, 264, 10.1016/j.cell.2015.02.047 · DOI · Paper page
- Psachoulia, 2016, IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation, Brain, 139, 3121, 10.1093/brain/aww254 · DOI · Paper page
- Suárez-Fariñas, 2013, Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis, J. Allergy Clin. Immunol., 132, 361, 10.1016/j.jaci.2013.04.046 · DOI · Paper page
- Czarnowicki, 2019, Atopic dermatitis endotypes and implications for targeted therapeutics, J. Allergy Clin. Immunol., 143, 1, 10.1016/j.jaci.2018.10.032 · DOI · Paper page
- Yu, 2019, A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor, J. Allergy Clin. Immunol., 143, 2108, 10.1016/j.jaci.2018.11.036 · DOI · Paper page
- Kyoreva, 2021, CYP1A1 enzymatic activity influences skin inflammation via regulation of the AHR pathway, J. Investig. Dermatol., 141, 1553, 10.1016/j.jid.2020.11.024 · DOI
- Musso, 1994, Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes, Blood, 83, 1408, 10.1182/blood.V83.5.1408.1408 · DOI · Paper page
- Huang, 2023, Tryptophan, an important link in regulating the complex network of skin immunology response in atopic dermatitis, Front. Immunol., 14
- Castro-Portuguez, 2020, Kynurenine pathway, NAD+ synthesis, and mitochondrial function: targeting tryptophan metabolism to promote longevity and healthspan, Exp. Gerontol., 132, 10.1016/j.exger.2020.110841 · DOI · Paper page
- Xu, 2022, Metabolic rewiring of kynurenine pathway during hepatic ischemia-reperfusion injury exacerbates liver damage by impairing NAD homeostasis, Adv. Sci., 9, 10.1002/advs.202204697 · DOI
- Ito, 2003, Tryptophan metabolism was accelerated by exercise in rat, Adv. Exp. Med. Biol., 527, 531, 10.1007/978-1-4615-0135-0_61 · DOI
- Dehhaghi, 2022, The role of kynurenine pathway and NAD+ metabolism in myalgic encephalomyelitis/chronic fatigue syndrome, Aging Dis., 13, 698, 10.14336/AD.2021.0824 · DOI
- Newman, 2021, Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells, Mol. Cell, 81, 2290, 10.1016/j.molcel.2021.03.019 · DOI
- Conejos, 2021, Supplementing with l-tryptophan increases medium protein and alters expression of genes and proteins involved in milk protein synthesis and energy metabolism in bovine mammary cells, Int. J. Mol. Sci., 22, 1, 10.3390/ijms22052751 · DOI
- Xue, 2023, Tryptophan metabolism in health and disease, Cell Metab., 35, 1304, 10.1016/j.cmet.2023.06.004 · DOI · Paper page
- Hernandez, 2024, Sex differences in branched-chain amino acid and tryptophan metabolism and pathogenesis of youth-onset type 2 diabetes, J. Clin. Endocrinol. Metab., 109, e1345, 10.1210/clinem/dgad708 · DOI
- Cussotto, 2020, Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation, Front. Immunol., 11, 2020, 10.3389/fimmu.2020.00557 · DOI · Paper page
- Tuomainen, 2018, Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals, Nutr. Diabetes, 8, 35, 10.1038/s41387-018-0046-9 · DOI · Paper page
- Hu, 2022, Update of indoles: promising molecules for ameliorating metabolic diseases, Biomed. Pharmacother., 150, 10.1016/j.biopha.2022.112957 · DOI
- Zhang, 2024, Anti-adipogenesis effect of indole-3-acrylic acid on human preadipocytes and HFD-induced zebrafish, Acta Diabetol., 61, 975, 10.1007/s00592-024-02256-7 · DOI
- Wang, 2024, Heterogeneously elevated branched-chain/aromatic amino acids among new-onset type-2 diabetes mellitus patients are potentially skewed diabetes predictors, World J. Diabetes, 15, 53, 10.4239/wjd.v15.i1.53 · DOI
- M. Simonato, S. Dall’Acqua, C. Zilli, S. Sut, R. Tenconi, N. Gallo, P. Sfriso, L. Sartori, F. Cavallin, U. Fiocco, P. Cogo, P. Agostinis, A. Aldovini, D. Bruttomesso, R. Marcolongo, S. Comai, A. Baritussio, Tryptophan metabolites, cytokines, and fatty acid binding protein 2 in myalgic encephalomyelitis/chronic fatigue syndrome, Biomedicines 9 (2021) 1724. https://doi.org/10.3390/biomedicines9111724. · DOI
- Taenzer, 2023, Urine metabolite analysis to identify pathomechanisms of long COVID: a pilot study, Int. J. Tryptophan Res., 16, 10.1177/11786469231220781 · DOI
- Kashi, 2019, The IDO metabolic trap hypothesis for the etiology of ME/CFS, Diagnostics, 9, 82, 10.3390/diagnostics9030082 · DOI
- Kavyani, 2024, Dysregulation of the kynurenine pathway, cytokine expression pattern, and proteomics profile link to symptomology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Mol. Neurobiol., 61, 3771, 10.1007/s12035-023-03784-z · DOI
- Brown, 2020, Intestinal dysbiosis and tryptophan metabolism in autoimmunity, Front. Immunol., 11, 1741, 10.3389/fimmu.2020.01741 · DOI
- Criado, 2009, Indoleamine 2,3 dioxygenase–mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis, Arthritis Rheum., 60, 1342, 10.1002/art.24446 · DOI · Paper page
- Sofia, 2018, Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis, Inflamm. Bowel Dis., 24, 1471, 10.1093/ibd/izy103 · DOI · Paper page
- Nikolaus, 2017, Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases, Gastroenterology, 153, 1504, 10.1053/j.gastro.2017.08.028 · DOI · Paper page
- Nikolaus, 2017, Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases, Gastroenterology, 153, 1504, 10.1053/j.gastro.2017.08.028 · DOI · Paper page
- Metghalchi, 2015, Indoleamine 2,3-dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of interleukin-10 production, Cell Metab., 22, 460, 10.1016/j.cmet.2015.07.004 · DOI
- Ghia, 2009, Serotonin has a key role in pathogenesis of experimental colitis, Gastroenterology, 137, 1649, 10.1053/j.gastro.2009.08.041 · DOI · Paper page
- Pongratz, 2019, Tryptophan metabolism in rheumatoid arthritis is associated with rheumatoid factor and predicts joint pathology evaluated by the Rheumatoid Arthritis MRI Score (RAMRIS), Clin. Exp. Rheumatol., 37, 450
- Moulin, 2023, Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis, Ann. Rheum. Dis., 83, 312, 10.1136/ard-2023-224014 · DOI
- Merlo, 2020, Differential roles of IDO1 and IDO2 in T and B cell inflammatory immune responses, Front. Immunol., 11, 2020, 10.3389/fimmu.2020.01861 · DOI
- Scott, 2009, The immunoregulatory enzyme IDO paradoxically drives B cell-mediated Autoimmunity1, J. Immunol., 182, 7509, 10.4049/jimmunol.0804328 · DOI
- Seymour, 2024, Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice, J. Clin. Investig., 134, 10.1172/JCI167671 · DOI
- Kargbo, 2023, Tryptamines and mental health: activating the 5-HT receptor for therapeutic potential, ACS Med. Chem. Lett., 14, 1331, 10.1021/acsmedchemlett.3c00390 · DOI
- Johnson, 2024, Alzheimer’s and metabolism wed with IDO1, Science, 385, 826, 10.1126/science.adr5836 · DOI
- Minhas, 2024, Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies, Science, 385, 10.1126/science.abm6131 · DOI · Paper page
- Knapskog, 2023, Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer’s disease, Alzheimer’s Dement., 19, 5573, 10.1002/alz.13162 · DOI
- Tafti, 2024, Mult. Scler.
- Nourbakhsh, 2018, Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course, Ann. Clin. Transl. Neurol., 5, 1211, 10.1002/acn3.637 · DOI
- Lim, 2017, Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression, Sci. Rep., 7
- Sundaram, 2014, Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies, J. Neuroinflamm., 11, 204, 10.1186/s12974-014-0204-5 · DOI · Paper page
- Dongol, 2023, Quinolinic acid impairs mitophagy promoting microglia senescence and poor healthspan in C. elegans: a mechanism of impaired aging process, Biol. Direct., 18, 86, 10.1186/s13062-023-00445-y · DOI
- Foster, 1984, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid, Neurosci. Lett., 48, 273, 10.1016/0304-3940(84)90050-8 · DOI · Paper page
- Fallarino, 2003, Modulation of tryptophan catabolism by regulatory T cells, Nat. Immunol., 4, 1206, 10.1038/ni1003 · DOI · Paper page
- Mezrich, 2010, An interaction between Kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells, J. Immunol., 185, 3190, 10.4049/jimmunol.0903670 · DOI · Paper page
- Pallotta, 2011, Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells, Nat. Immunol., 12, 870, 10.1038/ni.2077 · DOI · Paper page
- Van der Leek, 2017, The kynurenine pathway As a novel link between allergy and the gut microbiome, Front. Immunol., 8, 10.3389/fimmu.2017.01374 · DOI
- Mellor, 2004, Ido expression by dendritic cells: tolerance and tryptophan catabolism, Nat. Rev. Immunol., 4, 762, 10.1038/nri1457 · DOI · Paper page
- Xu, 2008, IDO: a double-edged sword for TH1/TH2 regulation, Immunol. Lett., 121, 1, 10.1016/j.imlet.2008.08.008 · DOI
- Esmaeili, 2022, The role of indoleamine 2,3-dioxygenase in allergic disorders, Mol. Biol. Rep., 49, 3297, 10.1007/s11033-021-07067-5 · DOI
- Wallet, 2005, Immunoregulation of dendritic cells, Clin. Med. Res., 3, 166, 10.3121/cmr.3.3.166 · DOI · Paper page
- H. Xu, T.B. Oriss, M. Fei, A.C. Henry, B.N. Melgert, L. Chen, A.L. Mellor, D.H. Munn, C.G. Irvin, P. Ray, A. Ray, Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation, 2008. www.pnas.org/cgi/content/full/. · DOI · Paper page
- Lau, 2021, Role of maternal tryptophan metabolism in allergic diseases in the offspring, Clin. Exp. Allergy, 51, 1346, 10.1111/cea.13953 · DOI
- Gostner, 2016, Tryptophan metabolism in allergic disorders, Int. Arch. Allergy Immunol., 169, 203, 10.1159/000445500 · DOI
- Liu, 2021, Role of tryptophan metabolism in cancers and therapeutic implications, Biochimie, 182, 131, 10.1016/j.biochi.2021.01.005 · DOI
- Peyraud, 2022, Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives, Front. Immunol., 13, 10.3389/fimmu.2022.807271 · DOI · Paper page
- van Baren, 2015, Tryptophan-degrading enzymes in tumoral immune resistance, Front. Immunol., 6, 10.3389/fimmu.2015.00034 · DOI · Paper page
- Hennequart, 2017, Constitutive IDO1 expression in Human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance, Cancer Immunol. Res., 5, 695, 10.1158/2326-6066.CIR-16-0400 · DOI · Paper page
- Zelenay, 2015, Cyclooxygenase-dependent tumor growth through evasion of immunity, Cell, 162, 1257, 10.1016/j.cell.2015.08.015 · DOI · Paper page
- Fiore, 2022, Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling, Mol. Cell, 82, 920, 10.1016/j.molcel.2022.02.007 · DOI · Paper page
- Bod, 2017, IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma, Oncoimmunology, 6, 1, 10.1080/2162402X.2016.1278331 · DOI
- Ramspott, 2018, Emerging role of IL-4–induced gene 1 as a prognostic biomarker affecting the local T-cell response in human cutaneous melanoma, J. Investig. Dermatol., 138, 2625, 10.1016/j.jid.2018.06.178 · doi:10.1016/j.jid.2018.06.178
- Sun, 2022, IL4I1 and tryptophan metabolites enhance AHR signals to facilitate colorectal cancer progression and immunosuppression, Am. J. Transl. Res., 14, 7758
- Balakrishna, 2021, Serotonin pathway in cancer, Int. J. Mol. Sci., 22, 1268, 10.3390/ijms22031268 · doi:10.3390/ijms22031268
- Dizeyi, 2011, Serotonin activates MAP kinase and PI3K/akt signaling pathways in prostate cancer cell lines, Urologic Oncol.: Semin. Original Investig., 29, 436, 10.1016/j.urolonc.2009.09.013 · DOI
- Zhu, 2022, 5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis, Neuron, 110, 2268, 10.1016/j.neuron.2022.04.024 · DOI
- Zakharia, 2021, Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma, J. Immunother. Cancer, 9, 10.1136/jitc-2020-002057 · DOI
- Forrest, 2013, Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway, Neuroscience, 254, 241, 10.1016/j.neuroscience.2013.09.034 · DOI · Paper page
- Hörsch, 2021, Long-term treatment with Telotristat Ethyl in patients with carcinoid syndrome symptoms: results from the TELEPATH study, Neuroendocrinology, 112, 298, 10.1159/000516958 · doi:10.1159/000516958
- Sarkar, 2004, Indole-3-carbinol and prostate cancer, J. Nutr., 134, 3493S, 10.1093/jn/134.12.3493S · DOI · Paper page
- Brown, 2011, The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome, Gastroenterology, 141, 507, 10.1053/j.gastro.2011.05.005 · DOI · Paper page
- Namkung, 2018, Inhibition of serotonin synthesis induces negative hepatic lipid balance, Diabetes Metab. J., 42, 233, 10.4093/dmj.2017.0084 · DOI
Cited by
Santerre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04255-4
Metadata
- Authors
- Gabela, A. M., Mthembu, N., & Hadebe, S.
- Venue
- Immunology Letters
- Publisher
- Elsevier BV
- Published
- 2026-02
- Volume
- 277
- Pages
- 107093
- ISSN
- 0165-2478
- Cited by
- 32
- References
- 23
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- South African Medical Research Council
- University of Cape Town
- National Research Foundation (138072)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.